2013 BRFSS Asthma Call-Back Survey Prevalence Tables

TABLE 4b. Estimated percent reporting an asthma attack or episode in the past year among adults1 with active2 asthma by state/territory – BRFSS Asthma Call-back Survey Land Line Sample, United States, 2013

State/Territory Sample
size±
Attack in past year No attack in past year No symptoms in past year
Sample
size
% SE§ 95% CI Sample
size
% SE 95% CI Sample
size
% SE 95% CI
Alabama 135 87 52.9 9.0 (35.3 – 70.5) 38 N/A N/A (N/A – N/A) 10 N/A N/A (N/A – N/A)
Arizona 105 63 53.0 11.1 (31.2 – 74.8) 31 N/A N/A (N/A – N/A) 11 N/A N/A (N/A – N/A)
California 182 83 38.0 5.7 (26.8 – 49.2) 85 57.0 5.9 (45.4 – 68.6) 14 N/A N/A (N/A – N/A)
Connecticut 231 113 49.5 6.5 (36.8 – 62.2) 96 44.9 6.6 (32.0 – 57.8) 22 5.5 1.5 (2.6 – 8.4)
Florida 765 445 63.5 4.9 (53.9 – 73.1) 260 29.6 4.4 (21.0 – 38.2) 60 6.9 1.9 (3.2 – 10.6)
Georgia 131 66 63.1 7.7 (48.0 – 78.2) 53 33.1 7.5 (18.4 – 47.8) 12 N/A N/A (N/A – N/A)
Hawaii 110 51 50.2 10.2 (30.2 – 70.2) 41 27.4 7.2 (13.3 – 41.5) 18 N/A N/A (N/A – N/A)
Indiana 334 195 50.9 5.4 (40.3 – 61.5) 108 35.1 5.2 (24.9 – 45.3) 31 N/A N/A (N/A – N/A)
Iowa 212 93 41.7 6.6 (28.8 – 54.6) 92 41.3 7.1 (27.4 – 55.2) 27 N/A N/A (N/A – N/A)
Kansas 649 324 47.7 3.8 (40.3 – 55.1) 259 42.9 3.9 (35.3 – 50.5) 66 9.4 1.7 (6.1 – 12.7)
Kentucky 361 222 54.2 5.0 (44.4 – 64.0) 121 37.8 4.9 (28.2 – 47.4) 18 N/A N/A (N/A – N/A)
Louisiana 140 69 47.4 9.2 (29.4 – 65.4) 53 43.9 9.8 (24.7 – 63.1) 18 N/A N/A (N/A – N/A)
Maine 236 120 48.7 5.7 (37.5 – 59.9) 88 37.5 5.7 (26.3 – 48.7) 28 13.8 3.9 (6.2 – 21.4)
Maryland 247 117 48.8 5.9 (37.2 – 60.4) 99 41.4 5.8 (30.0 – 52.8) 31 N/A N/A (N/A – N/A)
Massachusetts 147 70 51.5 9.3 (33.3 – 69.7) 61 37.0 8.1 (21.1 – 52.9) 16 N/A N/A (N/A – N/A)
Michigan 490 271 58.3 4.1 (50.3 – 66.3) 181 35.7 3.9 (28.1 – 43.3) 38 6.0 1.7 (2.7 – 9.3)
Mississippi 213 118 36.9 6.8 (23.6 – 50.2) 86 48.7 8.6 (31.8 – 65.6) 9 N/A N/A (N/A – N/A)
Missouri 217 103 49.0 6.3 (36.7 – 61.3) 98 46.2 6.4 (33.7 – 58.7) 16 N/A N/A (N/A – N/A)
Montana 277 132 46.9 7.9 (31.4 – 62.4) 114 49.3 8.1 (33.4 – 65.2) 31 3.8 1.1 (1.6 – 6.0)
Nebraska 284 137 46.0 8.9 (28.6 – 63.4) 126 42.7 8.2 (26.6 – 58.8) 21 N/A N/A (N/A – N/A)
Nevada 114 52 53.7 8.7 (36.6 – 70.8) 47 31.5 7.1 (17.6 – 45.4) 15 N/A N/A (N/A – N/A)
New Hampshire 225 107 47.6 6.7 (34.5 – 60.7) 100 39.7 6.5 (27.0 – 52.4) 18 N/A N/A (N/A – N/A)
New Jersey 281 124 40.9 5.9 (29.3 – 52.5) 132 46.6 5.9 (35.0 – 58.2) 25 N/A N/A (N/A – N/A)
New Mexico 237 119 44.8 5.9 (33.2 – 56.4) 101 48.7 6.0 (36.9 – 60.5) 17 N/A N/A (N/A – N/A)
New York 110 64 63.4 7.8 (48.1 – 78.7) 40 34.7 7.8 (19.4 – 50.0) 6 N/A N/A (N/A – N/A)
North Carolina 122 68 61.1 7.3 (46.8 – 75.4) 44 27.1 6.3 (14.8 – 39.4) 10 N/A N/A (N/A – N/A)
Ohio 257 141 52.2 6.0 (40.4 – 64.0) 95 37.5 5.9 (25.9 – 49.1) 21 N/A N/A (N/A – N/A)
Oklahoma 234 132 58.5 5.8 (47.1 – 69.9) 76 28.8 5.1 (18.8 – 38.8) 26 N/A N/A (N/A – N/A)
Oregon 182 105 72.5 5.5 (61.7 – 83.3) 61 23.5 5.2 (13.3 – 33.7) 16 N/A N/A (N/A – N/A)
Pennsylvania 265 135 47.8 5.7 (36.6 – 59.0) 110 42.1 6.0 (30.3 – 53.9) 20 N/A N/A (N/A – N/A)
Rhode Island 206 91 46.3 7.0 (32.6 – 60.0) 87 39.8 6.3 (27.5 – 52.1) 28 N/A N/A (N/A – N/A)
Texas 232 106 38.0 6.9 (24.5 – 51.5) 105 50.3 7.5 (35.6 – 65.0) 21 N/A N/A (N/A – N/A)
Utah 320 165 52.6 5.9 (41.0 – 64.2) 134 40.3 5.8 (28.9 – 51.7) 21 N/A N/A (N/A – N/A)
Vermont 200 86 45.3 6.9 (31.8 – 58.8) 95 47.7 6.9 (34.2 – 61.2) 19 N/A N/A (N/A – N/A)
Washington 295 141 46.2 5.7 (35.0 – 57.4) 123 46.6 6.0 (34.8 – 58.4) 31 7.3 1.8 (3.8 – 10.8)
West Virginia 125 71 60.5 5.8 (49.1 – 71.9) 47 36.9 5.7 (25.7 – 48.1) 7 N/A N/A (N/A – N/A)
Wisconsin 190 89 37.2 7.0 (23.5 – 50.9) 85 53.1 8.2 (37.0 – 69.2) 16 N/A N/A (N/A – N/A)
Puerto Rico 246 100 42.5 6.1 (30.5 – 54.5) 125 47.9 6.0 (36.1 – 59.7) 21 N/A N/A (N/A – N/A)
38 state total 9,307 4,775 50.8 1.5 (47.9 – 53.7) 3,697 40.8 1.5 (37.9 – 43.7) 835 8.5 0.7 (7.1 – 9.9)
Median     48.9       40.8       6.9    
Range     36.9-72.5       23.5-57.0       3.8-13.8    

1 Aged ≥ 18 years

2 Reported any of the following during the past year: asthma medication use, asthma symptoms, or MD visits for asthma

± Landline sample size excludes “DK/Refused”

§ Standard error

Confidence interval

N/A: Estimate not available (N/A) if the unweighted sample size for the denominator was < 50 or if the relative standard error was > 0.30